Isomorphic Lab’s proprietary drug-discovery model is a major advance, but scientists developing open-source tools are left ...

The unified JavaScript runtime standard is an idea whose time has come. Here’s an inside look at the movement for server-side JavaScript interoperability.

Threat actors are abusing Pastebin comments to distribute a new ClickFix-style attack that tricks cryptocurrency users into ...

To be human is, fundamentally, to be a forecaster. Occasionally a pretty good one. Trying to see the future, whether through the lens of past experience or the logic of cause and effect, has helped us ...

Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday.